2024 Voting Results

Voting Results of the Annual General Meeting of Shareholders of QIAGEN N.V.

QIAGEN's Annual General Meeting of Shareholders (the "Annual Meeting") was held on June 21, 2024. The following actions were taken at the Annual Meeting:

  1. Opening (no voting item)
  2. Managing Board Report for the year ended December 31, 2023 ("Calendar Year 2023") (no voting item)
  3. Compliance with Dutch Corporate Governance Code (no voting item)
  4. Supervisory Board Report on the Company's Annual Accounts (the "Annual Accounts") for Calendar Year 2023 (no voting item)
  5. Proposal to adopt the Annual Accounts of QIAGEN N.V. (the "Company") for the Calendar Year 2023 was approved

Votes for

Votes against

Votes abstain

Number of shares

169,563,398

437,647

708,610

Percentage

99.74%

0.26%

-

6. Proposal to cast a favorable non-binding advisory vote in respect of the Remuneration Report 2023 was approved

Votes for

Votes against

Votes abstain

Number of shares

153,298,897

16,607,441

803,317

Percentage

90.23%

9.77%

-

  1. Reservation and dividend policy (no voting item)
  2. Proposal to discharge from liability of the Managing Directors for the performance of their duties during Calendar Year 2023 was approved

Votes for

Votes against

Votes abstain

Number of shares

164,535,634

5,344,962

829,059

Percentage

96.85%

3.15%

-

9. Proposal to discharge from liability of the Supervisory Directors for the performance of their duties during Calendar Year 2023 was approved

Votes for

Votes against

Votes abstain

Number of shares

164,520,214

5,359,799

829,642

Percentage

96.84%

3.16%

-

1

10a. Proposal to reappoint Dr. Metin Colpan as a Supervisory Director of the Company for a term running up to and including the date of the Annual General Meeting in 2025 was approved

Votes for

Votes against

Votes abstain

Number of shares

160,292,518

10,354,571

62,566

Percentage

93.93%

6.07%

-

10b. Proposal to reappoint Dr. Toralf Haag as a Supervisory Director of the Company for a term running up to and including the date of the Annual General Meeting in 2025 was approved

Votes for

Votes against

Votes abstain

Number of shares

170,603,666

42,757

63,232

Percentage

99.97%

0.03%

-

10c. Proposal to reappoint Prof. Dr. Ross L. Levine as a Supervisory Director of the Company for a term running up to and including the date of the Annual General Meeting in 2025 was approved

Votes for

Votes against

Votes abstain

Number of shares

169,082,097

1,564,541

63,017

Percentage

99.08%

0.92%

-

10d. Proposal to reappoint Prof. Dr. Elaine Mardis as a Supervisory Director of the Company for a term running up to and including the date of the Annual General Meeting in 2025 was approved

Votes for

Votes against

Votes abstain

Number of shares

168,053,354

2,593,321

62,980

Percentage

98.48%

1.52%

-

10e. Proposal to reappoint Dr. Eva Pisa as a Supervisory Director of the Company for a term running up to and including the date of the Annual General Meeting in 2025 was approved

Votes for

Votes against

Votes abstain

Number of shares

169,837,957

804,241

67,457

Percentage

99.53%

0.47%

-

10f. Proposal to reappoint Mr. Lawrence A. Rosen as a Supervisory Director of the Company for a term running up to and including the date of the Annual General Meeting in 2025 was approved

Votes for

Votes against

Votes abstain

Number of shares

152,957,724

17,688,755

63,176

Percentage

89.63%

10.37%

-

2

10g. Proposal to reappoint Mr. Stephen H. Rusckowski as a Supervisory Director of the Company for a term running up to and including the date of the Annual General Meeting in 2025 was approved

Votes for

Votes against

Votes abstain

Number of shares

165,413,049

5,233,478

63,128

Percentage

96.93%

3.07%

-

10h. Proposal to reappoint Ms. Elizabeth E. Tallett as a Supervisory Director of the Company for a term running up to and including the date of the Annual General Meeting in 2025 was approved

Votes for

Votes against

Votes abstain

Number of shares

138,308,560

32,337,463

63,632

Percentage

81.05%

18.95%

-

10i. Proposal to reappoint Mr. Bert van Meurs as a Supervisory Director of the Company for a term running up to and including the date of the Annual General Meeting in 2025 was approved

Votes for

Votes against

Votes abstain

Number of shares

170,042,089

604,227

63,339

Percentage

99.65%

0.35%

-

10j. Proposal to reappoint Ms. Eva van Pelt as a Supervisory Director of the Company for a term running up to and including the date of the Annual General Meeting in 2025 was approved

Votes for

Votes against

Votes abstain

Number of shares

169,257,599

1,389,076

62,980

Percentage

99.19%

0.81%

-

11a. Proposal to reappoint Mr. Thierry Bernard as a Managing Director of the Company for a term running up to and including the date of the Annual General Meeting in 2025 was approved

Votes for

Votes against

Votes abstain

Number of shares

168,599,213

1,615,996

494,446

Percentage

99.05%

0.95%

-

11b. Proposal to reappoint Mr. Roland Sackers as a Managing Director of the Company for a term running up to and including the date of the Annual General Meeting in 2025 was approved

Votes for

Votes against

Votes abstain

Number of shares

168,926,696

1,288,623

494,336

Percentage

99.24%

0.76%

-

3

12a. Proposal to adopt the Remuneration Policy with respect to the Supervisory Board was approved

Votes for

Votes against

Votes abstain

Number of shares

146,317,062

24,319,182

73,411

Percentage

85.75%

14.25%

-

12b. Proposal to determine the Remuneration of the members of the Supervisory Board was approved

Votes for

Votes against

Votes abstain

Number of shares

146,629,189

24,011,699

68,767

Percentage

85.93%

14.07%

-

13. Proposal to reappoint KPMG Accountants N.V. as auditors of the Company for the calendar year ending December 31, 2024 was approved

Votes for

Votes against

Votes abstain

Number of shares

170,429,724

192,166

87,765

Percentage

99.89%

0.11%

-

14. Proposal to appoint Ernst & Young Accountants LLP as auditors of the Company for the calendar year ending December 31, 2025 was approved

Votes for

Votes against

Votes abstain

Number of shares

170,526,084

116,662

66,909

Percentage

99.93%

0.07%

-

15a. Proposal to authorize the Supervisory Board, until December 21, 2025 to issue a number of ordinary shares and financing preference shares and grant rights to subscribe for such shares, the aggregate par value of which shall be equal to the aggregate par value of fifty percent (50%) of shares issued and outstanding in the capital of the Company as at December 31, 2023 as included in the Annual Accounts for Calendar Year 2023 was approved

Votes for

Votes against

Votes abstain

Number of shares

139,237,436

31,391,984

80,235

Percentage

81.60%

18.40%

-

15b. Proposal to authorize the Supervisory Board, until December 21, 2025 to restrict or exclude the pre-emptive rights with respect to issuing ordinary shares or granting subscription rights, the aggregate par value of such shares or subscription rights shall be up to a maximum of ten percent (10%) of the aggregate par value of all shares issued and outstanding in the capital of the Company as at December 31, 2023 was approved

Votes for

Votes against

Votes abstain

Number of shares

167,392,438

3,213,774

103,443

Percentage

98.12%

1.88%

-

4

16. Proposal to authorize the Managing Board, until December 21, 2025, to acquire shares in the Company's own share capital was approved

Votes for

Votes against

Votes abstain

Number of shares

170,288,388

166,977

254,290

Percentage

99.90%

0.10%

-

17. Proposal to approve discretionary rights for the Managing Board to implement a capital repayment by means of a synthetic share repurchase was approved

a. Proposal to amend the Company's Articles of Association in accordance with the draft deed of amendment to the Company's Articles of Association (Part I) to, amongst other things, increase the par value per ordinary share by an amount to be determined by the Managing Board of the Company;

b. Proposal to amend the Company's Articles of Association in accordance with the draft deed of amendment of the Company's Articles of Association (Part II) to, amongst other things, consolidate the ordinary shares at a consolidation ratio to be determined by the Managing Board, subject to the approval of the Supervisory Board (the reverse stock split);

c. Proposal to amend the Company's Articles of Association in accordance with the draft deed of amendment of the Company's Articles of Association (Part III) to decrease the par value per ordinary share to an amount of EUR 0.01 and to repay to the shareholders an amount to be determined by the Managing Board, subject to the approval of the Supervisory Board, which amount will at maximum be USD 300 million in the aggregate; and

d. Proposal to authorize each member of the Managing Board of the Company and each lawyer, (candidate) civil law notary and paralegal working at De Brauw Blackstone Westbroek N.V. to execute the three deeds of amendment of the Company's Articles of Association (Part I, II and III)

Votes for

Votes against

Votes abstain

Number of shares

169,595,262

51,431

1,062,962

Percentage

99.97%

0.03%

-

18. Proposal to approve the cancellation of fractional ordinary shares held by the Company was approved

Votes for

Votes against

Votes abstain

Number of shares

170,588,847

50,866

69,942

Percentage

99.97%

0.03%

-

  1. Questions (no voting item)
  2. Closing (no voting item)

5

Attachments

  • Original Link
  • Original Document
  • Permalink

Disclaimer

Qiagen NV published this content on 27 June 2024 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 27 June 2024 11:24:50 UTC.